Cambridge, United Kingdom

Anja Sibylle Tessarz

This inventor holds 2 USPTO granted patents. Top assignee: Biogen Ma Inc.. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anja Sibylle Tessarz. Retrieved from https://idiyas.com/inventor/anja-sibylle-tessarz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Anja Sibylle Tessarz: Pioneering Innovation in Antibody Development

Introduction: Anja Sibylle Tessarz is a distinguished inventor based in Cambridge, GB, with a focus on groundbreaking antibody technologies. With a portfolio of two patents, her work contributes significantly to advancements in the treatment and prevention of serious medical conditions, including fibrosis and cancer.

Latest Patents: Anja's latest patents center around Anti-alpha V beta 6 antibodies, which are humanized antibodies and antibody fragments designed to bind to αvβ6. These innovations include methods for using these antibodies and fragments to diagnose, treat, and prevent αvβ6-mediated diseases such as acute tissue injury, fibrosis, and cancer.

Career Highlights: Currently, Anja is affiliated with Biogen MA Inc., a company renowned for its commitment to innovative biotechnology solutions. Her contributions in this environment enable significant advancements in therapeutic antibody development and application.

Collaborations: Anja collaborates with several esteemed professionals, including her coworkers Sheila Marie Violette and Paul H. Weinreb. Together, they explore innovative pathways in biomedical research, focusing on improving patient outcomes through novel therapeutic strategies.

Conclusion: Anja Sibylle Tessarz exemplifies the spirit of innovation within the biotechnology field. Her patents not only reflect her dedication to advancing science but also underscore her essential role in the ongoing battle against critical health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…